Olon Group is a global leader in the development and production of active pharmaceutical ingredients (APIs) for CDMO and generic markets, integrating chemical synthesis and biological processes while …

Olon Group is a global leader in the development and production of active pharmaceutical ingredients (APIs) for Contract Development and Manufacturing Organisations (CDMO) and generic markets.

Jan 30, 2024 · A GMP High Potency Active Pharmaceutical Ingredient (HPAPI) suite, currently under construction at the Olon USA site in Concord, Ohio, is the center of excellence for early development …

Olon Group is a global leader in the development and production of active pharmaceutical ingredients (APIs) for CDMO and generic markets, integrating chemical synthesis and biological processes while …

Sep 4, 2024 · Olon announces a new acquisition, continuing its growth path in the pharmaceutical industry.

Olon Sites: 11 facilities spanning over 3 continents, with strong capabilities in both chemical synthesis and microbial fermentation.

Sustainable technologies delivering science | Olon is a global leader in the development and production of active pharmaceutical ingredients (APIs) for CDMO and Generics.

Olon is a company that specializes in the development and production of active pharmaceutical ingredients (APIs). It offers chemical synthesis and microbial biomanufacturing solutions.

Mar 28, 2025 · Stay informed with the latest news from Olon, the global leader in developing and producing Active Pharmaceutical Ingredients (APIs).

Oct 6, 2023 · Olon Group is a global leader in the development and production of active pharmaceutical ingredients (APIs) for CDMO and generic markets, integrating chemical synthesis and biological …